Primary Mediastinal B-cell Lymphoma (PMBCL)
6 clinical trials · Condition
◉ Watch Primary Mediastinal B-cell Lymphoma (PMBCL)
| Record | Firm | Date |
|---|---|---|
| DALY II USA/ MB-CART2019.1 for DLBCL (NCT04792489) | Miltenyi Biomedicine GmbH | 2021-05-25 |
| ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) (NCT04049513) | Malaghan Institute of Medical Research | 2019-10-11 |
| Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma (NCT02348216) | Kite, A Gilead Company | 2015-04-21 |
Track Primary Mediastinal B-cell Lymphoma (PMBCL) automatically
Every clearance here is in the API, with alerts when new ones post.